home > articles > cystic fibrosis > cystic fibrosis: therapeutic options for co-management
Glutathione Articles - Cystic Fibrosis
Cystic Fibrosis: Therapeutic Options For Co-management
Patrick L. Bufi, N.D.
Alternative Medicine Review 1997;2(2):104-115.
> download full text
version as a PDF
ABSTRACT
Cystic fibrosis (CF) is a cruel and deadly disease affecting the
respiratory system, digestive system, endocrine system, and reproductive
system. CF is a disease of greatly varied symptomatology due to the many
possible mutations contributing to genotype and phenotype. This creates a
disease complex with a wide range of disorders that can ultimately include
chronic obstructive pulmonary disease, CF-associated liver fibrosis,
diabetes mellitus, cholelithiasis, and arthritis. The primary destructive
component, however, is seen in the lungs, resulting in the uncertain life
span associated with this disease. Controlling bacterial infection and
managing the status of macro- and micronutrients remain a constant
challenge. Due to the severity of this recessive disorder, conventional
medical treatment is mandatory. However, many alternative medical options,
such as coenzyme Q10, oligomeric proanthocyanidins, antioxidants, and
amino acid therapies have proven to be significant contributors to the
treatment of one of the ultimate co-management diseases of our time.
Glutathione Experts | What is Glutathione (GSH)?
| Glutathione Articles |
GSH FAQs
| GSH & Diseases |
Contact
